High Proinsulin with Low Glucose and Normal Insulin/C-peptide: Diagnostic Significance
The most likely explanation for high proinsulin with low glucose levels and normal insulin and C-peptide levels is an islet cell tumor (insulinoma) or nesidioblastosis, which causes inappropriate proinsulin secretion leading to hypoglycemia. 1
Pathophysiology and Diagnostic Significance
- The persistence of inappropriately increased plasma insulin concentrations with low glucose concentration strongly suggests the presence of an islet cell tumor 1
- An increase in the ratio of fasting proinsulin to insulin in an individual with hypoglycemia is particularly suggestive of an islet cell tumor 1
- Proinsulin levels above 5 pmol/L with blood glucose levels below 2.5 mmol/L during a 72-hour fast test represent the best criterion for diagnosing endogenous hyperinsulinism, with 100% diagnostic specificity and sensitivity 2
- Normal C-peptide levels with elevated proinsulin may indicate a defect in the conversion of proinsulin to insulin, which can occur in certain islet cell tumors 1
Differential Diagnosis
1. Insulinoma
- Insulinomas are characterized by inappropriate insulin secretion with elevated proinsulin levels 3
- The diagnostic triad (Whipple's triad) includes:
- Symptomatic hypoglycemia
- Low blood glucose (<55 mg/dL)
- Resolution of symptoms after glucose administration 3
- Insulinomas typically show elevated C-peptide levels (>0.2 nmol/L) with blood glucose below 2.5 mmol/L 2
2. Nesidioblastosis
- Adult-onset nesidioblastosis presents with hyperinsulinemic hypoglycemia without a discrete tumor 4
- Unlike insulinomas, C-peptide levels may not be consistently elevated in nesidioblastosis when glucose is below 2.5 mmol/L 2
- Diagnosis is challenging and often requires extensive testing to rule out insulinoma 4
3. Genetic Disorders
- Genetic abnormalities that result in the inability to convert proinsulin to insulin can be inherited in an autosomal dominant pattern 1
- These conditions typically present with mild glucose intolerance rather than hypoglycemia 1
- Mutations in proinsulin processing enzymes can lead to high proinsulin with normal insulin levels 1
4. Surreptitious Insulin Administration
- This can be ruled out by measuring C-peptide, which would be low or suppressed with exogenous insulin administration 1, 5
- Normal C-peptide levels in this case indicate endogenous insulin production 5
Diagnostic Approach
Confirm Hypoglycemia with Inappropriate Insulin/Proinsulin Secretion
Imaging Studies
- If endogenous hyperinsulinism is confirmed, proceed with pancreatic imaging:
- CT or MRI scans
- Consider endoscopic ultrasound (82% sensitivity for localizing insulinomas) 3
- If endogenous hyperinsulinism is confirmed, proceed with pancreatic imaging:
Additional Testing
Management Considerations
- Surgical treatment is recommended for localized insulinomas, with a cure rate of approximately 90% 3
- Preoperative stabilization of blood glucose through dietary measures and/or diazoxide may be necessary 3
- For nesidioblastosis or unresectable tumors, diazoxide therapy can be an effective and safe alternative 4
- Caution is advised when using somatostatin analogs due to potential worsening of hypoglycemia 3
Important Clinical Pearls
- The absence of changes in glucose, insulin, and proinsulin concentrations in an individual with fasting hypoglycemia makes the diagnosis of an islet cell tumor unlikely 1
- Measurement of C-peptide is essential in investigating nondiabetic hypoglycemia to rule out hypoglycemia due to surreptitious insulin administration 1, 5
- Hyperinsulinemia of insulinoma and selected cases of functional hypoglycemia are associated with a greater percentage of proinsulin compared to normal 6